Long-life Endurance Exercise and Healthy Aging

NCT ID: NCT05053282

Last Updated: 2021-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-01

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project aims to explore the mechanisms by which lifelong exercise can promote healthy aging and slow down the negative impact of aging on the muscular system, immunity and the circadian system. The main goal of the project is to investigate the effect of lifelong endurance exercise on physical fitness, body composition, bone density and selected hormonal, biochemical, histological and molecular indicators of metabolic health and circadian clock function based on blood, immune cell and skeletal muscle tissue analyses in volunteers differentiated by age and weekly volume of physical activity.

It is hypothesized that lifelong endurance exercise may have beneficial effects on the circadian system stability and many, but not all health outcomes. Osteopenia/osteoporosis and low-grade malnutrition may be more prevalent in the group of endurance-trained senior runners.

In order to achieve the above research aims, sixty male subjects in total will be recruited according to inclusion and exclusion criteria. Four groups of subjects will differ according to their age and physical activity levels:

* a group of endurance-trained seniors (age range 65 - 75 year old, n=15) ● a group of sedentary seniors (age range 65 - 75 year old, n=15)
* a group of well endurance-trained young men (age range 20 - 30 year old, n=15) ● a group of sedentary young men (age range 20 - 30 year old, n=15).

Subjects must meet the following inclusion criteria:

1. for athletes' groups: defined as more than 150 minutes of running activity per week; for young athletes at least 3 years and for master athletes at least 15 years history of running.
2. for groups less active than recommended: no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week.

The standard inclusion criterion for every group will be body mass index (range 18.5-30 kg/m2).

No experimental study has been published on the potential of life-long exercise to attenuate the aging-induced disorganization of the circadian system and thus to promote healthy aging. In this aspect, the proposed study is original and up-to-date. Moreover, also other aspects of the study, e.g. exercise and inflammaging or the risks (besides the benefits) of the long-life endurance training on bone tissue etc. have been studied only scarcely. Therefore, more scientific information is needed before it can be safely prescribed to the aging population

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

master endurance athletes

men aged 65 to 75 with more than 150 minutes of running activity per week at least 15 years history of running

endurance running exercise

Intervention Type OTHER

regular competitive or non-competitive running of medium and/or high intensity with the duration at least 20 minutes per session

elderly sedentary

men aged 65 to 75 with no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week according the ACSM recommendations

No interventions assigned to this group

young endurance athletes

men aged 20 to 30 with more than 150 minutes of running activity per week at least 3 years history of running

endurance running exercise

Intervention Type OTHER

regular competitive or non-competitive running of medium and/or high intensity with the duration at least 20 minutes per session

young sedentary

men aged 20 to 30 with no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week according the ACSM recommendations

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

endurance running exercise

regular competitive or non-competitive running of medium and/or high intensity with the duration at least 20 minutes per session

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

for athletes' groups (master - 65 - 75 years old, and young athletes - 20 - 30 years old)

* more than 150 minutes of running activity which is by ACSM considered as vigorous intensity of endurance running for young athletes at least 3 years and for master athletes at least 15 years
* body mass index (BMI index) - range 18.5-30 kg/m2

for groups less active than recommended (sedentary young and elderly)

* no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week
* body mass index (BMI index) - range 18.5-30 kg/m2

Exclusion Criteria

* recent or current infection
* malignant disease
* uncontrolled hypertension (higher than 160 / 95mmHG)
* congestive heart failure (NYHA grade III and IV)
* unstable angina pectoris
* recent myocardial infarction (during the last 6 months)
* severe cardiac arrhythmia (anamnestic)
* chronic obstructive pulmonary disease
* presence of severe pulmonary, pleural or pericardial disease
* severe asthma
* recent sudden stroke (during the last 6 months)
* epilepsy
* insulin-dependent diabetes mellitus
* unstable bone lesions with a high risk of fractures
* other chronic diseases, at the discretion of the responsible doctor
* states of mental incompetence (severe anxiety and depression, dementia, alcoholism , or other dependencies, mental retardation)
* conditions complicating regular physical activity (uncontrollable pain, severe arthritis, planned knee / hip endoprosthesis, pathological fractures (last 6 months), amputation, use of walker, wheelchair
* pharmacological interference (e.g., steroids, nonsteroidal anti-inflammatory agents, immunosuppressive and antineoplastic drugs, beta blockers, statins)
* the use of performance-enhancing drugs in the past and during the study period
Minimum Eligible Age

20 Years

Maximum Eligible Age

75 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Physiko- und Rheumatherapie Gesellschaft m.b.H.

UNKNOWN

Sponsor Role collaborator

University of Padova

OTHER

Sponsor Role collaborator

University of Roma La Sapienza

OTHER

Sponsor Role collaborator

University of Primorska

OTHER

Sponsor Role collaborator

Comenius University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ján Cvečka, PhD.

Role: PRINCIPAL_INVESTIGATOR

Comenius University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Comenius University in Bratislava, Faculty of physical education and sport Bratislava, Slovakia

Bratislava, , Slovakia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Slovakia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Milan Sedliak, assoc. prof.

Role: CONTACT

+421907247021

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Milan Sedliak, assoc. prof.

Role: primary

+421907247021

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

305041X157

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Healthy Aging Through Movement
NCT05772884 COMPLETED NA
Healthy Aging Through Optimized Exercise
NCT07093216 NOT_YET_RECRUITING NA